Violation Code: 290
FDA Violation
Charge Code: DE IMP GMP
Violation Details
- Violation Code (ASC ID)
- 290
- Charge Code
- DE IMP GMP
- Description
- The article is subject to refusal of admission pursuant to section 801(a)(1) in that it appears that the methods used in, or the facilities or controls used for, the manufacture of the device do not conform to the applicable requirements of section 520(f).
- Legal Section
- 801(a)(1); NON CONFORMING MANUFACTURING PRACTICES
Most Affected Firms
| # | Firm Name | Location | Cases |
|---|---|---|---|
| 1 | Tinopal Surgical Corp. (Pvt) Ltd. | Sialkot, PAKISTAN | 387 |
| 2 | Merits Health Products Co., Ltd. | Taichung City, TAIWAN | 193 |
| 3 | Convertors De Mexico | Juarez, MEXICO | 119 |
| 4 | Washington Surgical International | Sialkot, PAKISTAN | 59 |
| 5 | K T Surgico (PVT) Ltd. | Sialkot, PAKISTAN | 44 |
| 6 | Shanghai Multi-Med Union Co., Ltd | Shanghai, CHINA | 39 |
| 7 | AAKK SURGICAL CORPORATION | Sialkot, PAKISTAN | 39 |
| 8 | Blacksmith Surgica | Karachi, PAKISTAN | 33 |
| 9 | K Plus International | Sialkot, PAKISTAN | 31 |
| 10 | Diligent Medical Services | Sialkot, PAKISTAN | 29 |
| 11 | Garana Industries | Sialkot, PAKISTAN | 26 |
| 12 | Faizan Surgical | Sialkot, PAKISTAN | 19 |
| 13 | Quality Point International | Sialkot, PAKISTAN | 18 |
| 14 | Y.Z. Corporation | Sialkot, PAKISTAN | 18 |
| 15 | Productos Medline, S.A. de C.V. | Nuevo Laredo, MEXICO | 17 |
| 16 | N.D. Surgical Industries | Sialkot, PAKISTAN | 17 |
| 17 | Sobytex Inst | Sialkot, PAKISTAN | 17 |
| 18 | MEDIZOLE ENTERPRISES | Sialkota, PAKISTAN | 17 |
| 19 | SIMRIX Surgical Co. | Sialkot, PAKISTAN | 16 |
| 20 | Renix Intl | Sialkot, PAKISTAN | 14 |
Recent Import Refusals
| Date | Product | Firm |
|---|---|---|
| 1/13/2026 | FORCEPS, GENERAL & PLASTIC SURGERY 79GEN | |
| 1/13/2026 | FORCEPS, GENERAL & PLASTIC SURGERY 79GEN | |
| 1/13/2026 | FORCEPS, GENERAL & PLASTIC SURGERY 79GEN | |
| 1/13/2026 | FORCEPS, GENERAL & PLASTIC SURGERY 79GEN | |
| 1/13/2026 | FORCEPS, GENERAL & PLASTIC SURGERY 79GEN | |
| 12/17/2025 | HEMOSTAT 79HRQ | |
| 12/12/2025 | FORCEPS, GENERAL & PLASTIC SURGERY 79GEN | |
| 12/5/2025 | SCISSORS, GENERAL USE, SURGICAL 79LRW | |
| 12/5/2025 | HOOK, SURGICAL, GENERAL & PLASTIC SURGERY 79GDG | |
| 12/3/2025 | HOLDER, NEEDLE 78FHQ | |
| 12/2/2025 | CANNULA, SURGICAL, GENERAL & PLASTIC SURGERY 79GEA | SAAMS INSTRUMENTSPAKISTAN |
| 11/28/2025 | HAMMER, SURGICAL 79FZY | FIRST MED INSTRUMENTSPAKISTAN |
| 11/19/2025 | SET, AUDIOMETER CALIBRATION 77EWA | CATAMOUNTPAKISTAN |
| 11/19/2025 | SET, AUDIOMETER CALIBRATION 77EWA | CATAMOUNTPAKISTAN |
| 11/19/2025 | SET, AUDIOMETER CALIBRATION 77EWA | CATAMOUNTPAKISTAN |
Frequently Asked Questions
What is FDA violation code 290?
290 is an FDA violation code that indicates: "The article is subject to refusal of admission pursuant to section 801(a)(1) in that it appears that the methods used in, or the facilities or controls used for, the manufacture of the device do not conform to the applicable requirements of section 520(f).". This violation is based on 801(a)(1); NON CONFORMING MANUFACTURING PRACTICES of the Federal Food, Drug, and Cosmetic Act.
How many import refusals have been issued for violation 290?
According to FDA Import Refusal data, there have been 1993 import refusals issued for violation code 290, affecting 353 unique firms.
When was the most recent refusal for violation 290?
The most recent import refusal for violation 290 was on January 13, 2026.
What products are commonly refused for violation 290?
Products commonly refused under violation 290 include: FORCEPS, GENERAL & PLASTIC SURGERY. These products were refused entry because they did not meet FDA requirements.
What is the legal basis for FDA violation code 290?
Violation code 290 is based on 801(a)(1); NON CONFORMING MANUFACTURING PRACTICES of the Federal Food, Drug, and Cosmetic Act (FD&C Act). This section of the law establishes requirements that imported products must meet to be allowed entry into the United States.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.